Business
Media
Conferences
Publications
CME/CE
Resources
Subscribe

|Videos|June 29, 2022

Dr. Rovner on adherence to AUA publication guidelines for SUI literature

Author(s)Urology Times staff

Eric S. Rovner, MD, professor of Urology, Medical University of South Carolina (MUSC), discusses the abstract, “Revisiting adherence to the AUA publication guidelines for SUI literature,” which was presented at the 2022 AUA Annual Meeting.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

Retrospective study suggests differences in OAB therapy persistence among older adults

ByUnwanaobong Nseyo, MD, MHS

June 20th 2026

Keith Xavier, MD, highlights UUI outcomes with ITNM across care settings

ByKeith Xavier, MD, URPS

May 27th 2026

Implantable tibial nerve stimulation outperforms sham in INTIBIA Pivotal Trial

ByCatherine A. Matthews, MD, FACOG, FACS, FPMRS

May 17th 2026

Charles Powell, MD, highlights Neuspera System’s 12-month UUI outcomes

ByCharles R. Powell, MD

May 6th 2026

Charles Powell, MD, on GLP-1 use and sacral neuromodulation outcomes

ByCharles R. Powell, MD

April 30th 2026

Latest CME

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

Jason Hafron, MD; Aaron D. Berger, MD; Arpeet Shah, MD

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Radioligand Therapy 101: The Science Behind the Strategy

Radioligand Therapy 101: The Science Behind the Strategy

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP

Trending on Urology Times

Unmet needs and emerging solutions in MRI-guided prostate cancer care

HHS requests testosterone therapy label updates, citing new safety data

Microbial dysbiosis may predict response to CBM588 in mRCC

Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC

Retrospective study suggests differences in OAB therapy persistence among older adults